Erratum : Technical standards and guidelines for myotonic dystrophy type 1 testing (Genet Med (2009)) DOI: 10.1097/GIM.0b013e3181abce0f);Technical standards and guidelines for myotonic dystrophy type 1 testing

Genetics in Medicine

Volumn 11, Issue 7, 2009, Pages 552-555

  Prior, Thomas W ^a,b  

^a Laboratory Quality Assurance Committee   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

CTG repeats; Genetic testing; Genotype; Myotonic dystrophy type 1; Phenotype

Indexed keywords

MYOTONIC DYSTROPHY PROTEIN KINASE; PROTEIN KINASE;

AUTOSOMAL DOMINANT INHERITANCE; CATARACT; CHECKLIST; DISEASE SEVERITY; GENE MUTATION; HUMAN; MENTAL DEFICIENCY; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; NEWBORN PERIOD; ONSET AGE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; PROFESSIONAL PRACTICE; REVIEW; SOUTHERN BLOTTING; TECHNICAL AID; TRINUCLEOTIDE REPEAT;

EID: 68749114098     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2015.176     Document Type: Erratum

References (17)

1. Harper PS, editor. Myotonic dystrophy, 2nd ed. Philadelphia: W.B. Saunders, 1989.
2. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
3. Fu YH, Pizzuti A, Fenwick RG Jr, King J, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258.
4. Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 1992;255:1253-1255.
5. Redman JB, Fenwick RG Jr, Fu YH, Pizzuti A, Caskey CT. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA 1993;269:1960-1965.
6. Tsilfidis C, MacKenzie AE, Mettler G, Barceló J, Korneluk RG. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet 1992;1:192-195.
7. Ranum LP, Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet 2004;74:793-804.
8. Charlet-BN, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002;10:45-53.
9. Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001;29:40-47.
10. Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-867.
11. Thorton CA, Johnson K, Moxley RT III. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 1994;35:104-107.
12. Martorell L, Monckton DG, Sanchez A, Lopez de Munain A, Baiget M. Frequency and stability of the myotonic dystrophy type 1 premutation. Neurology 2001;56:328-335.
13. International Myotonic Dystrophy Consortium (IDMC). New nomenclature and DNA testing guidelines for myotonic dystrophy type I (DM1). Neurology 2000;54:1218-1221.
14. Buxton J, Shelbourne P, Davie J, et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992;355: 547-548.
15. Shelbourne P, Davies J, Buxton J, Anvret M, et al. Direct diagnosis of myotonic dystrophy with a disease-specific DNA marker. N Engl J Med 1993;328:471-475.
16. Petronis A, Heng HH, Tatuch Y, et al. Direct detection of expanded trinucleotide repeats using PCR and DNA hybridization techniques. Am J Med Genet 1996;67:85-91.
17. Guida M, Marger RS, Papp AC, et al. A molecular protocol for diagnosing myotonic dystrophy. Clin Chem 1995;41:69-72.